financial post
New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-‘749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed
Financial Post • 3 MONTHS AGO
Pentagon steps up media restrictions, now requiring approval before reporting even unclassified info
Financial Post • 3 MONTHS AGO
Venezuelan president’s YouTube account offline as tensions with US escalate
Financial Post • 3 MONTHS AGO
Power, politics and performance: Russia’s revamped Intervision song contest names a winner
Financial Post • 3 MONTHS AGO
Emerging TikTok deal with China ensures US control of board and crucial algorithm, White House says
Financial Post • 3 MONTHS AGO
Champagne tries to sell Europe on Canadian energy, critical mineral exports
Financial Post • 3 MONTHS AGO
